Published in World J Gastroenterol on February 28, 2012
Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy. Liver Int (2013) 1.43
Non-invasive diagnosis of liver fibrosis in chronic hepatitis C. World J Gastroenterol (2014) 1.05
Impact of contacting study authors to obtain additional data for systematic reviews: diagnostic accuracy studies for hepatic fibrosis. Syst Rev (2014) 0.85
Non-invasive serum fibrosis markers: A study in chronic hepatitis. Bioimpacts (2015) 0.83
Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients. PLoS One (2015) 0.77
Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon. PLoS One (2016) 0.75
A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology (1983) 30.77
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology (2003) 16.40
Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology (2003) 10.25
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology (2006) 10.18
Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology (1994) 9.86
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol (2002) 8.21
Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology (2002) 6.92
Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol (2003) 5.17
National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10-12, 2002. Hepatology (2002) 5.16
Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet (1986) 3.64
Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology (2000) 3.49
Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem (2004) 3.45
Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem (2005) 2.99
Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs. JAMA (1999) 2.97
Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. J Hepatol (2007) 2.75
A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology (2005) 2.38
Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am J Gastroenterol (2001) 2.04
Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology (2005) 1.93
Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma. Cancer (2006) 1.92
Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterology (1988) 1.91
Factors predictive of a beneficial response to therapy of hepatitis C. Hepatology (1997) 1.90
EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. Consensus statement. J Hepatol (1999) 1.80
Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin Chem (2003) 1.65
Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol (1997) 1.39
Hepatitis C--global prevalence (update). Wkly Epidemiol Rec (2000) 1.36
Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups. J Viral Hepat (1997) 1.29
Natural history of hepatitis C. Am J Med (1999) 1.20
Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C. Histopathology (1998) 1.00
Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice? J Clin Gastroenterol (2008) 0.99
FibroQ: an easy and useful noninvasive test for predicting liver fibrosis in patients with chronic viral hepatitis. Chang Gung Med J (2009) 0.90
Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin. J Viral Hepat (2006) 0.88
Clinical significance of activity of ALT enzyme in patients with hepatitis C virus. World J Gastroenterol (2007) 0.82
Treatment of patients with chronic hepatitis C and cirrhosis. J Hepatol (1999) 0.78
Critical illness-related corticosteroid insufficiency in cirrhotic patients with acute gastroesophageal variceal bleeding: risk factors and association with outcome*. Crit Care Med (2014) 2.07
Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. Gastroenterology (2008) 1.81
Endoscopic mucosal resection for colonic non-polypoid neoplasms. Am J Gastroenterol (2005) 1.64
Predictive role of nuclear factor-kappaB activity in gastric cancer: a promising adjuvant approach with caffeic acid phenethyl ester. J Clin Gastroenterol (2007) 1.47
Hemodynamics and metabolic studies on septic shock in patients with acute liver failure. J Crit Care (2008) 1.46
Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock. Hepatology (2006) 1.15
Evaluation of depigmenting activity by 8-hydroxydaidzein in mouse B16 melanoma cells and human volunteers. Int J Mol Sci (2009) 1.08
A strong association between down-regulation of HLA-DR expression and the late mortality in patients with severe acute pancreatitis. Am J Gastroenterol (2006) 1.05
Amiloride modulates alternative splicing in leukemic cells and resensitizes Bcr-AblT315I mutant cells to imatinib. Cancer Res (2011) 1.01
Low serum concentration of apolipoprotein A-I is an indicator of poor prognosis in cirrhotic patients with severe sepsis. J Hepatol (2009) 1.00
Magnifying endoscopy with indigo carmine contrast for differential diagnosis of neoplastic and nonneoplastic colonic polyps. Dig Dis Sci (2004) 1.00
In vitro and in vivo melanogenesis inhibition by biochanin A from Trifolium pratense. Biosci Biotechnol Biochem (2011) 0.99
Murine tyrosinase inhibitors from Cynanchum bungei and evaluation of in vitro and in vivo depigmenting activity. Exp Dermatol (2011) 0.97
Combining induced mutation and protoplasting for strain improvement of Aspergillus oryzae for kojic acid production. Biotechnol Lett (2004) 0.96
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up. Hepatology (2013) 0.96
Endoscopic submucosal dissection for early gastric cancers: experience from a new endoscopic center in Taiwan. J Clin Gastroenterol (2008) 0.94
Evaluation of in vitro and in vivo depigmenting activity of raspberry ketone from Rheum officinale. Int J Mol Sci (2011) 0.93
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. J Infect Dis (2010) 0.90
FibroQ: an easy and useful noninvasive test for predicting liver fibrosis in patients with chronic viral hepatitis. Chang Gung Med J (2009) 0.90
CXC chemokine ligand 12/stromal cell-derived factor-1 regulates cell adhesion in human colon cancer cells by induction of intercellular adhesion molecule-1. J Biomed Sci (2012) 0.90
Proteomic analysis of the effects of baicalein on colorectal cancer cells. Proteomics (2012) 0.90
Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK/ NFκB signaling pathway in gastric cancer cells. J Biomed Sci (2014) 0.90
Stromal cell-derived factor-1/CXC receptor 4 and β1 integrin interaction regulates urokinase-type plasminogen activator expression in human colorectal cancer cells. J Cell Physiol (2012) 0.89
Induction of G2/M phase arrest and apoptosis by a novel enediyne derivative, THDB, in chronic myeloid leukemia (HL-60) cells. Toxicol In Vitro (2006) 0.89
Tyrosinase inhibitors isolated from the roots of Paeonia suffruticosa. J Cosmet Sci (2009) 0.88
Efficacy and safety of pegylated interferon alfa-2b and ribavirin combination therapy versus pegylated interferon monotherapy in hemodialysis patients: a comparison of 2 sequentially treated cohorts. Am J Kidney Dis (2013) 0.88
Critical illness-related corticosteroid insufficiency in patients with severe acute biliary pancreatitis: a prospective cohort study. Crit Care (2009) 0.86
Endoscopic resection of a large colonic leiomyoma. Chang Gung Med J (2002) 0.84
A novel indoloquinoline derivative, IQDMA, induces S-phase arrest and apoptosis in promyelocytic leukemia HL-60 cells. Cell Biol Toxicol (2006) 0.83
Mechanisms of cardiotoxin lll-induced apoptosis in human colorectal cancer colo205 cells. Clin Exp Pharmacol Physiol (2006) 0.83
Acute renal failure in cirrhotic patients with severe sepsis: value of urinary interleukin-18. J Gastroenterol Hepatol (2013) 0.82
Endoscopic hemorrhoidal ligation of symptomatic internal hemorrhoids. Gastrointest Endosc (2003) 0.82
Induction of G2/M phase arrest by squamocin in chronic myeloid leukemia (K562) cells. Life Sci (2005) 0.82
Induction of G2/M phase arrest and apoptosis by a novel enediyne derivative, THDA, in chronic myeloid leukemia (K562) cells. Mol Cell Biochem (2006) 0.81
Nasogastric feeding tube placement in patients with esophageal cancer: application of ultrathin transnasal endoscopy. Gastrointest Endosc (2006) 0.81
Stapled hemorrhoidopexy for prolapsed hemorrhoids in patients with liver cirrhosis; a preliminary outcome for 8-case experience. Int J Colorectal Dis (2007) 0.81
Squamocin modulates histone H3 phosphorylation levels and induces G1 phase arrest and apoptosis in cancer cells. BMC Cancer (2011) 0.81
Activation of neutral-sphingomyelinase, MAPKs, and p75 NTR-mediating caffeic acid phenethyl ester-induced apoptosis in C6 glioma cells. J Biomed Sci (2014) 0.81
Clinical features and outcome of chronic viral hepatitis with acute exacerbation in patients with concurrent infections of hepatitis B and C virus. Dig Dis Sci (2007) 0.80
Serum levels of apolipoprotein A-I and high-density lipoprotein can predict organ failure in acute pancreatitis. Crit Care (2015) 0.79
Tissue expression of the hepatitis C virus NS3 protein does not correlate with histological or clinical features in patients with chronic hepatitis C. Chang Gung Med J (2011) 0.79
Serum HCV RNA level is not associated with insulin resistance and metabolic syndrome in chronic hepatitis C patients with genotype 1 or 2 infection. Chang Gung Med J (2011) 0.78
Up-regulation of Bax and endonuclease G, and down-modulation of Bcl-XL involved in cardiotoxin III-induced apoptosis in K562 cells. Exp Mol Med (2006) 0.78
Evaluation of polyethylene glycol plus electrolytes in the treatment of severe constipation and faecal impaction in adults. Curr Med Res Opin (2005) 0.78
Endoscopic treatment of colorectal neoplasms: a simple and safe procedure to lower the incidence of colorectal cancers. Dig Dis Sci (2008) 0.77
Cytotoxic effects produced by arecoline correlated to epigenetic regulation in human K-562 cells. J Toxicol Environ Health A (2011) 0.77
A rare case of spontaneous resolution of eosinophilic ascites in a patient with primary eosinophilic gastroenteritis. Chang Gung Med J (2012) 0.76
Interleukin-17 induces CC chemokine receptor 6 expression and cell migration in colorectal cancer cells. J Cell Physiol (2015) 0.76
Clinical outcome of endoscopically removed early colorectal cancer. J Gastroenterol Hepatol (2003) 0.76
A double-blind randomized controlled study to evaluate the efficacy of low-dose oral interferon-alpha in preventing hepatitis C relapse. J Interferon Cytokine Res (2013) 0.75
Intermittent nasal carriage with Staphylococcus aureus within a menstrual cycle: Results from a prospective cohort of healthy carriers. Medicine (Baltimore) (2016) 0.75
Effect of oral esomeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. J Gastroenterol Hepatol (2007) 0.75
Distribution of Fatal Vibrio Vulnificus Necrotizing Skin and Soft-Tissue Infections: A Systematic Review and Meta-Analysis. Medicine (Baltimore) (2016) 0.75
Correction: Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma. PLoS One (2017) 0.75
Gingival metastasis from gallbladder cancer. Chang Gung Med J (2002) 0.75
How can colorectal neoplasms be treated during colonoscopy? World J Gastroenterol (2005) 0.75
The small molecule calactin induces DNA damage and apoptosis in human leukemia cells. Eur J Cancer Prev (2012) 0.75
Help-seeking behavior in Taiwanese woman with menopause-related mood symptoms. Chang Gung Med J (2009) 0.75
Inhibitory effect of a water extract from Pemphis acidula on melanogenesis in mouse B16 melanoma cells. J Cosmet Sci (2011) 0.75
Cytologic changes in small hepatocellular carcinomas after radiofrequency ablation. Acta Cytol (2002) 0.75
Elevated serum cholesterol levels in women with premenstrual dysphoric disorder. Int J Psychiatry Med (2011) 0.75
Corrigendum: Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis. Am J Gastroenterol (2016) 0.75